UNSPSC 51392801: Bemoradan

This classification denotes a phosphodiesterase inhibitor with the molecular formula C13H13N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G2S2V1ETBQ, chemically known as 7-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)-2h-1,4-benzoxazin-3(4h)-one but generally known as bemoradan, which bears US NIH Compound Identifier 5362399. European Medicines Agency schedules Bemoradan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05695MIG. The term BEMORADAN is an International Non-Proprietary Name.

UNSPSC 51392801 Bemoradan, a Commodity code, covers naloxone and drug deactivation systems that state and local health agencies procure to support overdose-response and harm-reduction community health initiatives. State and local governments buying under this code are acquiring pharmaceutical countermeasures and medical safety products in volumes ranging from hundreds to thousands of units annually, with delivery schedules tailored to public health operational needs. Issuing bodies include county health departments and state health agencies; Seminole County, Florida and the Texas Health and Human Services Commission appear in the recent record. Procurement vehicles include traditional competitive bidding (IFB) and exploratory requests for information (RFI) to assess vendor capability and market pricing before formal solicitation.

Recent activity centers on Florida and Texas. Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023, and a two-year initial contract term with a one-year renewal option. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to explore vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program, focusing on vendors' experience with direct contracting for self-insured health plans and government entities and their ability to negotiate net pricing models outside traditional pharmacy benefit manager and wholesaler channels. Both solicitations emphasize compliance with federal requirements, including E-Verify employment verification, drug-free workplace certification, and in the Seminole County case, adherence to FEMA-funded federal environmental and procurement regulations.